Ann Goding Sauer1, Ahmedin Jemal2, Edgar P Simard3, Stacey A Fedewa4. 1. Surveillance and Health Services Research Program, Intramural Research Department, American Cancer Society, 250 Williams Street, Atlanta, GA 30303-1002, United States. Electronic address: ann.godingsauer@cancer.org. 2. Surveillance and Health Services Research Program, Intramural Research Department, American Cancer Society, 250 Williams Street, Atlanta, GA 30303-1002, United States. 3. Epidemiology Department, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, United States. 4. Surveillance and Health Services Research Program, Intramural Research Department, American Cancer Society, 250 Williams Street, Atlanta, GA 30303-1002, United States; Epidemiology Department, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, United States.
Abstract
BACKGROUND: A positive association between recent Papanicolaou (Pap) test uptake and initiation of HPV vaccination among U.S. women has been reported. However, it is unknown whether recent Pap testing by HPV vaccination status varies by race/ethnicity. Discerning racial/ethnic variations is important given the higher prevalence of HPV types other than 16 and 18 in some racial/ethnic groups. We assessed whether uptake of recent Pap testing differed among women aged 21-30 years who had not initiated the HPV vaccination series versus those who had and whether this pattern differed by sociodemographic factors. METHODS: 2008, 2010, and 2013 National Health Interview Survey data were used to generate weighted prevalence estimates and 95% confidence intervals (CIs) (n=7095). Adjusted predicted marginal models were used to generate adjusted prevalence ratios (aPRs) to assess the relationship between recent Pap test uptake and HPV vaccination series initiation by race/ethnicity. RESULTS: The uptake of recent Pap testing among those who had not initiated the HPV vaccination series was significantly lower (81.0%) compared to those who had initiated vaccination (90.5%) (aPR=0.93, 95% CI: 0.90-0.96). This finding was consistent across most sociodemographic factors, though not statistically significant for Blacks, Hispanics, those with lower levels of education, or those with higher levels of income. CONCLUSION: Young women who had not initiated HPV vaccination were less likely to have had a recent Pap test compared to women who had initiated vaccination. Concerted efforts are needed to increase uptake of recommended cervical cancer screening and HPV vaccination among young women.
BACKGROUND: A positive association between recent Papanicolaou (Pap) test uptake and initiation of HPV vaccination among U.S. women has been reported. However, it is unknown whether recent Pap testing by HPV vaccination status varies by race/ethnicity. Discerning racial/ethnic variations is important given the higher prevalence of HPV types other than 16 and 18 in some racial/ethnic groups. We assessed whether uptake of recent Pap testing differed among women aged 21-30 years who had not initiated the HPV vaccination series versus those who had and whether this pattern differed by sociodemographic factors. METHODS: 2008, 2010, and 2013 National Health Interview Survey data were used to generate weighted prevalence estimates and 95% confidence intervals (CIs) (n=7095). Adjusted predicted marginal models were used to generate adjusted prevalence ratios (aPRs) to assess the relationship between recent Pap test uptake and HPV vaccination series initiation by race/ethnicity. RESULTS: The uptake of recent Pap testing among those who had not initiated the HPV vaccination series was significantly lower (81.0%) compared to those who had initiated vaccination (90.5%) (aPR=0.93, 95% CI: 0.90-0.96). This finding was consistent across most sociodemographic factors, though not statistically significant for Blacks, Hispanics, those with lower levels of education, or those with higher levels of income. CONCLUSION: Young women who had not initiated HPV vaccination were less likely to have had a recent Pap test compared to women who had initiated vaccination. Concerted efforts are needed to increase uptake of recommended cervical cancer screening and HPV vaccination among young women.
Authors: Leslie E Cofie; Jacqueline M Hirth; Fangjian Guo; Abbey B Berenson; Kyriakos Markides; Rebeca Wong Journal: Am J Prev Med Date: 2017-10-23 Impact factor: 5.043
Authors: Monica L Kasting; Shannon Wilson; Terrell W Zollinger; Brian E Dixon; Nathan W Stupiansky; Gregory D Zimet Journal: Prev Med Rep Date: 2016-12-21
Authors: Eva Herweijer; Adina L Feldman; Alexander Ploner; Lisen Arnheim-Dahlström; Ingrid Uhnoo; Eva Netterlid; Joakim Dillner; Pär Sparén; Karin Sundström Journal: PLoS One Date: 2015-07-28 Impact factor: 3.240
Authors: Christopher A Paynter; Benjamin J Van Treeck; Inge Verdenius; Agnes W Y Lau; Twinkle Dhawan; Kayla A Lash; Elizabeth A Bergamini; Chiazotam N Ekekezie; Amna M Hilal; Kristen N James; Sadie Alongi; Sean M Harper; Aaron J Bonham; Kathy B Baumgartner; Richard N Baumgartner; Diane M Harper Journal: Prev Med Rep Date: 2015-07-31
Authors: T J Palmer; M McFadden; K G J Pollock; K Kavanagh; K Cuschieri; M Cruickshank; S Nicoll; C Robertson Journal: Br J Cancer Date: 2016-01-22 Impact factor: 7.640